Platelet Membrane-Coated HGF-PLGA Nanoparticles Promote Therapeutic Angiogenesis and Tissue Perfusion Recovery in Ischemic Hindlimbs
Authors:
Open Access
- 26 December 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 8 (1) , 399-409
Abstract
Therapeutic angiogenesis has garnered significant attention as a potential treatment strategy for lower limb ischemic diseases. Although hepatocyte growth factor (HGF) has been identified as a key promoter of therapeutic angiogenesis, its clinical application is limited due to its short half-life. In this study, we successfully developed and characterized platelet membrane-coated HGF-poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs). These nanoparticles demonstrated enhanced capabilities to promote endothelial cell (EC) proliferation, migration, and tube formation in vitro. Additionally, their efficacy in improving tissue perfusion and promoting angiogenesis was confirmed in a hindlimb ischemia rat model. Our findings suggest that platelet membrane-coated HGF-PLGA-NPs could serve as a promising therapeutic approach for enhancing angiogenesis and restoring tissue perfusion in ischemic conditions.Keywords
Funding Information
- National Natural Science Foundation of China (81970417)
- National High Level Hospital Clinical Research Funding (2022-PUMCH-A-079)
- Chinese Academy of Medical Scienc (CAMS) Innovation Fund for Medical Sciences (CIFMS) (2022-I2M-1-019)
This publication has 35 references indexed in Scilit:
- Effect of PLGA raw materials on in vitro and in vivo performance of drug-loaded microspheresDrug Delivery and Translational Research, 2024
- Vascular restenosis reduction with platelet membrane coated nanoparticle directed M2 macrophage polarizationiScience, 2022
- Rationale and design for the study of recombinant human hepatocyte growth factor plasmid in the treatment of patients with chronic limb-threatening ischemia (HOPE CLTI): Randomized, placebo-controlled, double-blind, phase III clinical trialsAmerican Heart Journal, 2022
- Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapyJournal of Controlled Release, 2020
- Drug Targeting via Platelet Membrane–Coated NanoparticlesSmall Structures, 2020
- Global vascular guidelines on the management of chronic limb-threatening ischemiaJournal of Vascular Surgery, 2019
- Major Adverse Limb Events and Mortality in Patients With Peripheral Artery DiseaseJACC, 2018
- Cell Membrane Coating NanotechnologyAdvanced Materials, 2018
- Biomimetic nanoparticles for inflammation targetingActa Pharmaceutica Sinica B, 2018
- Cell membrane-derived nanomaterials for biomedical applicationsBiomaterials, 2017